CME Group Inc (NASDAQ:CME) Insider Kimberly S. Taylor Sells 8,125 Shares

CME Group Inc (NASDAQ:CME) insider Kimberly S. Taylor sold 8,125 shares of CME Group stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $150.00, for a total transaction of $1,218,750.00. Following the completion of the transaction, the insider now owns 120,590 shares of the company’s stock, valued at approximately $18,088,500. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

CME Group Inc (CME) traded down $0.26 during trading hours on Friday, hitting $146.05. 879,877 shares of the stock were exchanged, compared to its average volume of 1,528,743. CME Group Inc has a 12-month low of $113.27 and a 12-month high of $155.29. The stock has a market cap of $49,615.91, a P/E ratio of 33.12, a PEG ratio of 3.01 and a beta of 0.73. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The business had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.05 EPS. analysts expect that CME Group Inc will post 4.77 EPS for the current fiscal year.

The firm also recently disclosed a dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Thursday, December 28th will be paid a $3.50 dividend. The ex-dividend date of this dividend is Wednesday, December 27th. This is a boost from CME Group’s previous dividend of $3.25. CME Group’s dividend payout ratio is 59.86%.

Several large investors have recently modified their holdings of the company. Hudock Capital Group LLC raised its stake in CME Group by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 3,890 shares of the financial services provider’s stock worth $487,000 after acquiring an additional 20 shares during the period. Ropes Wealth Advisors LLC raised its stake in CME Group by 0.4% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 10,801 shares of the financial services provider’s stock worth $1,353,000 after acquiring an additional 38 shares during the period. Pekin Singer Strauss Asset Management IL grew its holdings in CME Group by 0.5% during the 2nd quarter. Pekin Singer Strauss Asset Management IL now owns 13,692 shares of the financial services provider’s stock valued at $1,715,000 after buying an additional 64 shares in the last quarter. Pitcairn Co. grew its holdings in CME Group by 2.2% during the 2nd quarter. Pitcairn Co. now owns 3,317 shares of the financial services provider’s stock valued at $416,000 after buying an additional 70 shares in the last quarter. Finally, IFP Advisors Inc grew its holdings in CME Group by 2.4% during the 2nd quarter. IFP Advisors Inc now owns 2,998 shares of the financial services provider’s stock valued at $375,000 after buying an additional 71 shares in the last quarter. Hedge funds and other institutional investors own 82.70% of the company’s stock.

Several brokerages recently commented on CME. Barclays began coverage on shares of CME Group in a research note on Friday, September 8th. They set an “overweight” rating and a $139.00 price objective for the company. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. UBS Group reissued a “buy” rating and issued a $135.00 price target (up previously from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Citigroup boosted their price objective on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Wells Fargo & Co boosted their price objective on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $141.75.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Week Herald and is owned by of Week Herald. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://weekherald.com/2017/12/30/cme-group-inc-cme-insider-sells-1218750-00-in-stock.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply